Location:  Home » Cancer Education » Preliminary data shows HDC+BMT combo therapy doesn't affect breast cancer survival rate; results questioned.: An article from: Transplant News  

Preliminary data shows HDC+BMT combo therapy doesn't affect breast cancer survival rate; results questioned.: An article from: Transplant News

Publisher: Transplant Communications, Inc.
Category: Book

Buy New: $5.95
as of 9/10/2010 13:44 CDT details



Seller: Amazon.com

Format: HTML
Media: Digital
Pages: 2


Availability: Available for download now

Editorial Reviews:

Product Description
This digital document is an article from Transplant News, published by Transplant Communications, Inc. on April 30, 1999. The length of the article is 436 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Preliminary data shows HDC+BMT combo therapy doesn't affect breast cancer survival rate; results questioned.
Publication: Transplant News (Newsletter)
Date: April 30, 1999
Publisher: Transplant Communications, Inc.
Volume: 9 Issue: 8 Page: NA

Distributed by Thomson Gale